BioSpace News Archive

Business

bluebird bio Completes Oncology Spin-Off Business, Establishes New Nest

bluebird bio has completed the spin-off of its oncology programs into the new business entity, 2seventy bio, Inc, which will begin trading on the Nasdaq this morning under the ticker symbol “TSVT.”

November 5, 2021
·
3 min read
·
Alex Keown
Job Trends

Amgen Breaks Ground on “Digitally Advanced” Smart Facility in Ohio

Amgen plans on investing $365 million in the site, including the introduction of 400 new job openings through the operations of its pharmaceutical packaging and assembly facility.

November 5, 2021
·
2 min read
·
Kaylei Whalen
Bio NC

BioCryst Presents New Data Showing Sustained Reduction of HAE Attack Rates and Improved Patient Satisfaction After Patients Switch to ORLADEYO®

BioCryst Pharmaceuticals, Inc. today announced new long-term efficacy and safety data from studies evaluating oral, once-daily ORLADEYO ®

November 5, 2021
·
10 min read
Business

Oncolytics Biotech® Reports 2021 Third Quarter Development Highlights and Financial Results

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and development highlights for the quarter ended September 30, 2021.

November 5, 2021
·
17 min read
SeaStar Medical Presents Data from SCD 005 Clinical Study at the American Society of Nephrology (ASN) Kidney Week 2021 Annual Meeting

SeaStar Medical announced new data from its SCD 005 clinical study to evaluate the safety and feasibility of the Selective Cytopheretic Device (SCD) in COVID-19 patients with acute kidney injury (AKI) and/or acute respiratory distress syndrome (ARDS).

November 5, 2021
·
3 min read
Business

Hillrom Exceeds Fourth Quarter Guidance With Strong Finish To Fiscal Year

Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full-year ended September 30, 2021 .

November 5, 2021
·
24 min read
Business

CASI Pharmaceuticals Partner, BioInvent, To Present Further Positive Clinical Data On BI-1206 At ASH 2021

CASI Pharmaceuticals, Inc. announced additional positive interim top-line data from its novel anti-FcγRIIB antibody BI-1206.

November 5, 2021
·
6 min read
Business

Forma Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on November 12, 2021

Forma Therapeutics Holdings, Inc. today announced that it will release third quarter 2021 financial results Friday, Nov. 12, 2021.

November 5, 2021
·
1 min read
Genetown

Abcuro to Present Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T Cells

Abcuro, Inc. will present initial results from a Phase 1 open-label trial of ABC008 in inclusion body myositis (IBM) at American College of Rheumatology Convergence 2021.

November 5, 2021
·
5 min read
Deals

AVROBIO Announced Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AVROBIO, Inc. today announced that the company has granted a non-statutory stock option for the purchase of up to 120,000 shares of the company’s common stock to the company’s new Chief Medical Officer, Essra Ridha, M.D., as an inducement award under the company’s 2019 Inducement Plan.

November 5, 2021
·
5 min read